<SEC-DOCUMENT>0001213900-25-079448.txt : 20250821
<SEC-HEADER>0001213900-25-079448.hdr.sgml : 20250821
<ACCEPTANCE-DATETIME>20250821175719
ACCESSION NUMBER:		0001213900-25-079448
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250821
DATE AS OF CHANGE:		20250821

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Carisma Therapeutics Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				262025616
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-87951
		FILM NUMBER:		251241833

	BUSINESS ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 401
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		2674916422

	MAIL ADDRESS:	
		STREET 1:		3675 MARKET STREET
		STREET 2:		SUITE 401
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sesen Bio, Inc.
		DATE OF NAME CHANGE:	20180516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Eleven Biotherapeutics, Inc.
		DATE OF NAME CHANGE:	20100223

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HealthCap VII, L.P.
		CENTRAL INDEX KEY:			0001645161
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		18 AVENUE D'OUCHY
		CITY:			CH 1006 LAUSANNE
		STATE:			V8
		ZIP:			1000-1018
		BUSINESS PHONE:		41 21 614 3500

	MAIL ADDRESS:	
		STREET 1:		18 AVENUE D'OUCHY
		CITY:			CH 1006 LAUSANNE
		STATE:			V8
		ZIP:			1000-1018
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: HealthCap VII, L.P. -->
          <cik>0001645161</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
      <dateOfEvent>08/19/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001485003</issuerCIK>
        <issuerCUSIP>14216R101</issuerCUSIP>
        <issuerName>Carisma Therapeutics Inc.</issuerName>
        <address>
          <com:street1>3675 Market Street</com:street1>
          <com:street2>Suite 401</com:street2>
          <com:city>Philadelphia</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19104</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>HealthCap VII, L.P.</personName>
          <personPhoneNum>4121 614 3500</personPhoneNum>
          <personAddress>
            <com:street1>Represented by HealthCap Investments SA</com:street1>
            <com:street2>23 Avenue Villamont</com:street2>
            <com:city>Lausanne</com:city>
            <com:stateOrCountry>V8</com:stateOrCountry>
            <com:zipCode>CH-1005</com:zipCode>
          </personAddress>
        </notificationInfo>
        <notificationInfo>
          <personName>Louis E. Rambo</personName>
          <personPhoneNum>(202) 416-6899</personPhoneNum>
          <personAddress>
            <com:street1>Proskauer Rose LLP</com:street1>
            <com:street2>1001 Pennsylvania Av, N.W. Ste 600 South</com:street2>
            <com:city>Washington</com:city>
            <com:stateOrCountry>DC</com:stateOrCountry>
            <com:zipCode>20004-2533</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001645161</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>HealthCap VII, L.P.</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>2721923.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2721923.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>2721923.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.5</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>HealthCap VII GP LLC</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>2721923.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2721923.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>2721923.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>6.5</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.001 per share</securityTitle>
        <issuerName>Carisma Therapeutics Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>3675 Market Street</com:street1>
          <com:street2>Suite 401</com:street2>
          <com:city>Philadelphia</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19104</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item5>
        <percentageOfClassSecurities>Item 5 of the Schedule 13D is hereby amended and supplemented as follows:

The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentage set forth in row 13 is based on approximately 41,788,096 shares of Common Stock outstanding as of August 5, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on August 7, 2024.</percentageOfClassSecurities>
        <numberOfShares>The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference.</numberOfShares>
        <transactionDesc>The Reporting Persons have effected the following transactions related to the Common Stock during the past 60 days:

Sold 39,100 shares of Common Stock on August 13, 2025 at a price of $0.289 per share; sold 81,003 shares of Common Stock on August 14, 2025 at a price of $0.284 per share; sold 50,402 shares of Common Stock on August 15, 2025 at a price of $0.284 per share; sold 72,617 shares of Common Stock on August 18, 2025 at a price of $0.28 per share; sold 184,500 shares of Common Stock on August 19, 2025 at a price of $0.247 per share; sold 134,000 shares of Common Stock on August 20, 2025 at a price of $0.228 per share; and sold 114,403  shares of Common Stock on August 21, 2025 at a price of $0.228 per share.

Except as set forth above, the Reporting Person has not effected any transactions related to the Common Stock during the past 60 days.</transactionDesc>
      </item5>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>HealthCap VII, L.P.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Dag Richter</signature>
          <title>By: HealthCap VII GP LLC, its general partner; By: HealthCap Investments SA, its investment manager; By: Dag Richter, Director</title>
          <date>08/21/2025</date>
        </signatureDetails>
        <signatureDetails>
          <signature>/s/ Fabrice Bernhard</signature>
          <title>By: HealthCap VII GP LLC, its general partner; By: HealthCap Investments SA, its investment manager; By: Fabrice Bernhard, General Manager</title>
          <date>08/21/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>HealthCap VII GP LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Dag Richter</signature>
          <title>By: HealthCap Investments SA, its investment manager; By: Dag Richter, Director</title>
          <date>08/21/2025</date>
        </signatureDetails>
        <signatureDetails>
          <signature>/s/ Fabrice Bernhard</signature>
          <title>By: HealthCap Investments SA, its investment manager; By: Fabrice Bernhard, General Manager</title>
          <date>08/21/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
